Receptor Dimerization‐Engineering Hydrogel to On‐Demand Regulate Cellular Behaviors
Advanced Healthcare Materials · 2026-11 · 15 (42)
DOI: 10.1002/adhm.71852 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 14.10.2026. Verfasst von Dan Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Medicine, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China. Hauptthemen laut MEDLINE: Hydrogels, Receptor Protein-Tyrosine Kinases. Die Arbeit nennt 57 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Scientific Research Fund of Chengdu Medical College, Chongqing Science Fund for Distinguished Young Scholars.
Abstract (Originalsprache)
Manipulation of cell‐surface receptor dimerization plays a critical role in modulating cellular behaviors, yet the controllable regulation and dimerization efficiency of receptors remain challenging. Here, a dynamic bispecific aptamer within triglycerol monostearate (TGMS) nanoparticles hydrogel termed REMEDY (receptor dimerization‐engineering directed hydrogel) was developed to modulate cellular behavior in an on‐demand manner. The REMEDY was fabricated by dual rolling circle amplification to deliver bispecific receptor tyrosine kinase (RTK) aptamers, thereby effectively promoting cell receptor dimerization. The TGMS nanoparticles loaded with restriction endonuclease Eco R I controllably released bispecific RTK aptamers through Eco R I‐triggered hydrogel disintegration in response to inflammation. The REMEDY successfully manipulated cell‐surface MET receptor dimerization and activated MAPK/ERK and PI3K/AKT signaling pathways. RNA sequencing analysis further revealed that activated pathways upregulated the expression of Krt1, Vegfb , while downregulating Il1b , which were closely associated with target cells proliferation, migration, and phenotypic polarization. A murine wound model was subsequently constructed to validate the practical therapeutic efficacy. Results demonstrated that REMEDY significantly enhanced wound healing rates by 26.35% in acute wounds and 58.70% in chronic wounds. The REMEDY provides a paradigm for converting nanoscale molecular operation to the microscale behaviors regulation and paves the pathway for advancing precise cell therapy in regenerative medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory Medicine, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
- School of Laboratory Medicine, Chengdu Medical College, Chengdu, Sichuan, China.
- Clinical Laboratory, the First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China.
Förderung
- National Natural Science Foundation of China
- Scientific Research Fund of Chengdu Medical College
- Chongqing Science Fund for Distinguished Young Scholars
Zitieren
APA
Li, D., Xie, Z., Niu, B., Yan, H., Yi, H., Ma, Y., Yin, Q., Deng, R., Zhao, S., Wu, D., Chen, M., Xu, Y., & Chang, K. (2026). Receptor Dimerization‐Engineering Hydrogel to On‐Demand Regulate Cellular Behaviors. Advanced Healthcare Materials, 15(42). https://doi.org/10.1002/adhm.71852
Vancouver
Li D, Xie Z, Niu B, Yan H, Yi H, Ma Y, et al. Receptor Dimerization‐Engineering Hydrogel to On‐Demand Regulate Cellular Behaviors. Advanced Healthcare Materials. 2026;15(42). doi:10.1002/adhm.71852
BibTeX
@article{Li2026,
author = {Li, Dan and Xie, Zuowei and Niu, Ben and Yan, Hong and Yi, Hong and Ma, Yifan and Yin, Qing and Deng, Ruijia and Zhao, Shuang and Wu, DongMing and Chen, Ming and Xu, Ying and Chang, Kai},
title = {Receptor Dimerization‐Engineering Hydrogel to On‐Demand Regulate Cellular Behaviors},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {42},
doi = {10.1002/adhm.71852}
}
EUVIMED